A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients
NCT06897657
·
clinicaltrials.gov ↗
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis, Relapsing-Remitting
Sponsor
Novartis Pharmaceuticals